Johns Hopkins Weight Management Center

Johns Hopkins Weight Management Center

For over 8 years, the Johns Hopkins Weight Management Center in Baltimore, MD has chosen Medifast products for their very low calorie diets. In clinical studies conducted by Johns Hopkins, males lost an average of 67.41 lbs. and females lost an average of 47.5 lbs. after being on the Medifast program for 16 weeks. Researchers concluded that the Medifast weight loss program provides a safe, effective means of weight reduction and are accompanied by significant improvements in coexisting health problems.

To learn more about this study please download the clinical abstract (PDF format).
Johns Hopkins Bloomberg School of Public Health.

The Johns Hopkins Bloomberg School of Public Health studied the efficacy of Medifast Plus for Diabetics by comparing Medifast to basic nutrition recommendations provided by the American Diabetic Association. Results of the study show that Type II Diabetics, using Medifast Plus for Diabetics, lost twice as much weight as those following the ADA's recommended food guidelines and were twice as likely to stick with the diet. Other improvements in health included:

* 19% decrease in insulin
* 12% decrease in fasting triglycerides
* 10% decrease in blood glucose
* 27% increase in quality of life
* 9% increase in HDL
* 7.5% decrease in body fat
* 8% decrease in blood pressure

The results of the study confirm the proven weight loss success of the Medifast Plus for Diabetics program.

View the final results
University of Vermont at Burlington (NIH commissioned study)

The University of Vermont at Burlington selected Medifast products for its NIH-commissioned Obesity Study entitled "Energy Metabolism in the Post-Obese State." This 4-year study will help define the metabolic consequences of the mutation in the B3AR gene in the regulation of daily energy expenditure and fat metabolism in older women. Researchers at the University of Vermont chose to use Medifast and Take Shape products in the study based on the recommendation of Dr. Lawrence Cheskin, Director of the Weight Management Center at Johns Hopkins University. You can learn more about this study by reading the NIH clinical abstract.

Maine State Prison

Prison physicians with prior experience using the Medifast weight loss program have treated obese inmates with Medifast’s very low calorie diet. Reports indicate that the improved health of these individuals directly translates to significant cost savings in medical care in a short period of time. With the initial weight losses achieved with the Medifast proven weight loss program, many patients have already reduced or discontinued medications needed to treat associated health conditions including hypertension, diabetes and hypercholesterolemia, among others.